The 2023 Producing Area Cooperation Meeting of China Medico Corporation was held in Xi'an On May 23, 2023.
Hirate Takemi, minister of Tsumura Pharmaceuticals department,,Suyama Hitoshi, minister of Tsumura Pharmaceuticals Production Management Department, Jinbou Tomokazu, minister of Tsumura Cultivation Technology Development Department, Kumazawa Hiroaki, supervisor of the Pharmaceuticals Business Department, Nose Yoshiaki, minister of the Pharmaceuticals Business Department, and leaders such as Kimura Shintarou and Naganawa Takanao attended the meeting in person and online.
Li Gang, General Manager of Ping'an Tsumura &Co., Shenzhen Tsumura &Co., and China Medico Corporation, Watanabe Yoshiharu, Deputy General Manager of Ping'an Tsumura &Co., Executive Deputy General Manager of Shenzhen Tsumura &Co. and Deputy General Manager of China Medico Corporation, Chen Yanguo, Deputy General Manager of Ping'an Tsumura &Co., Executive Deputy General Manager of China Medico Corporation, and Takahashi Haruhiko, the chief Financial Officer of Ping'an Tsumura &Co. , attended the meeting in person.
Yao Ling, Deputy General Manager of Shenzhen Tsumura &Co., Li Shiyu, Minister of Planting Management Department, Li Lianguo, Minister of Business Department, Fuda Bushi and Xiao Pingkuo, Deputy Ministers of Business Department, and leaders and colleagues of Planting Management Department, Business Department, and Pingcun Pharmaceutical &Co. also attending this meeting.
Cao Lijuan and Liu Tianzhi, deputy general managers of China Medico Corporation, leaders and colleagues from the procurement department, planting management department, business department, quality management department, production department, and sales department, as well as representatives of dozens of domestic origin companies, attended the meeting together.
▲Welcome Speech by Liu Tianzhi, Deputy General Manager of China Medico Corporation
Liu Tianzhi, Deputy General Manager of China Medico Corporation, first warmly welcomed the attending leaders and representatives of various production companies, and gave a report on China Medico Corporation's business performance, Phase III construction, future goals, and other aspects.
Mr. Liu pointed out that in the face of the pressure brought by the epidemic in 2022, all employees of the company and various production areas did not retreat. Under the correct leadership of General Manager Li Gang, and with the full assistance of Tsumura in Japan, Shanghai, Shenzhen, and various production areas, China Medico Corporation successfully completed its annual tasks, with an overall sales business exceeding 1.4 billion yuan, a significant increase in export business, and the third phase of construction successfully completed and put into operation. He expressed that in the face of the ever-changing market environment, China Medico Corporation hopes that companies from all regions will continue to work together, overcome difficulties together, and move forward bravely, to jointly draw a better blueprint.
▲ Yoshiharu Watanabe, Executive Officer of Tsumura Pharmaceuticals and Deputy General Manager of China Medico Corporation made a statement about the business vision in China
Yoshiharu Watanabe, Executive Officer of Tsumura Pharmaceuticals and Deputy General Manager of China Medico Corporation, made a statement about the business vision in China, formulation platforms, and mergers and acquisitions, and explained the basic policies and contents of China's major health business, traditional Chinese medicine business, and other Chinese businesses.
Hiroshi Hiroshi, the minister of Tsumura Pharmaceuticals department, provided a detailed introduction online about Tsumura's 2022 final accounts, Japan business, 2023 performance forecast, 2031 Tsumura vision, and Tsumura strategy. He hoped that companies from all production areas will strengthen their procurement, processing, and storage capabilities, to help achieve stable supply of raw materials and raw drugs, and promote win-win cooperation between production areas and Tsumura, and jointly contribute to people's health.
▲ Suyama Hitoshi , minister of the Tsumura Production Management Department, provided explanations about the Tsumura GACP management policies and related topics
Suyama Hitoshi, minister of the Tsumura Production Management Department, introduced the GACP management policy and provided detailed explanations on three topics: the correct use of pesticides, the correct production history information of Pharmaceuticals, and the specific authenticity of farmers.
Kumazawa Hiroaki, minister of the Pollution Countermeasures Department of the Cultivation Technology Development of Tsumura Raw Medicine Headquarters, explained online about the exogenous pollution of raw medicine. Detailed explanations were provided on the main causes of exogenous pollution, the risks and countermeasures of exogenous pollution in raw materials, as well as the future, corresponding measures, and strengthened content. Specific corresponding points in the actual operation of the pollution countermeasures department in Tsumura were also shared.
▲ Zhang Naiwu, minister of China Medico Corporation Planting Management Department, delivered a GACP management report
▲ Zhang Xu, minister of China Medico Corporation Quality Management Department, delivered the 2022 crude drug quality report
▲ Yao Xionghui, minister of China Medico Corporation Procurement Department, delivered the business situation report
The ministers of China Medico Corporation Planting Management Department, Quality Control Department, and Procurement Department respectively reported their work to the conference and provided special training on relevant professional issues.
▲Representatives from production companies communicated On site
The producing company shared their experience on long-term agreements, medicinal herb planting trends, and planting methods during the exchange and discussion session.
▲Yao Ling, Deputy General Manager of Shenzhen Tsumura &Co. made a speech
At the meeting, Yao Ling, Deputy General Manager of Shenzhen Tsumura &Co., congratulated China Medico Corporation on its achievements in 2022 and expressed gratitude to the producing companies that have always supported and helped Shenzhen Tsumura. She hoped to continue working together with the producing companies to achieve better goals.
▲ Li Gang, General Manager of China Medico Corporation, delivered a concluding speech
At the end of the meeting, Li Gang, General Manager of China Medico Corporation, delivered a concluding speech. Mr. Li stated that in the face of the impact of the epidemic, China Medico Corporation has successfully achieved its established goals and made significant progress and development. The achievement cannot be achieved without the care and support of various producing companies. Mr. Li expressed his gratitude to the various producing companies that supported and helped China Medico Corporation.
Mr. Li pointed out that it is necessary to strengthen close cooperation with companies from various production areas, improve work rigor, and ensure timely and sufficient delivery. He emphasized that under the guidance of national policies, we should enhance the awareness of being prepared for danger in times of peace, and continuously consolidate the foundation of medicinal material production while avoiding land disputes with grain to ensure the safety of traditional Chinese medicine production. At the same time, Mr. Li expressed the hope that companies from all production areas will jointly promote the fresh processing work, fully leverage their advantages and characteristics, and contribute to the intelligent development of the Chinese herbal medicine industry in the later stage.